""

Neuroendocrine tumors

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Metastatic Disease: First-Line-Therapy

There are currently no studies available

Metastatic Disease: Follow-Up Treatment

Title: A multicenter single-arm pilot study of ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors
Phase: II a
Contact: Elisabeth Lawrence / Kontaktperson
Clinical Investigator: Dr. Leonidas Apostolidis
Registration: Die Studie ist beim Deutsches Reigster Klinischer Studien registriert. DRKS00014689
EudraCT-Number: (siehe EU klinisches Studienregister) 2017-001207-68
Title: A Phase II, Open-label, Multicenter Trial to Investigate the Clinical Activity and Safety of Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3).
Phase: II
Contact: Elisabeth Lawrence / Kontaktperson
Clinical Investigator: Dr. Leonidas Apostolidis
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05289856
EudraCT-Number: (siehe EU klinisches Studienregister) 2021-000986-34

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Other study

There are currently no studies available